Chronic Fluoxetine Treatment and Brain Gene Expression
Author Information
Author(s): Maria Nordheim Alme, Karin Dagestad, Grethe Bramham, Clive R. Bramham
Primary Institution: University of Bergen
Hypothesis
Chronic fluoxetine administration leads to upregulation of genes associated with BDNF-induced long-term potentiation in specific brain regions.
Conclusion
Chronic fluoxetine treatment promotes gene expression linked to BDNF signaling and long-term synaptic plasticity in multiple brain regions.
Supporting Evidence
- Chronic fluoxetine administration led to significant upregulation of genes in the prefrontal cortex, hippocampus, and dentate gyrus.
- Neuritin, Narp, TIEG1, Carp, and Arl4d were identified as candidate effectors of chronic fluoxetine treatment.
- Acute fluoxetine treatment did not enhance gene expression in any of the brain regions studied.
Takeaway
Giving fluoxetine for a long time helps certain brain genes work better, which might help with mood and memory.
Methodology
Adult male Sprague-Dawley rats were treated with fluoxetine or saline, and gene expression was measured using semiquantitative real-time PCR.
Limitations
The study primarily focuses on male rats, which may limit the generalizability of the findings to females.
Participant Demographics
Adult male Sprague-Dawley rats weighing 190–300 g.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website